ReviewiScience2025
Unlocking the synergistic potential of green metallic nanoparticles and antibiotics for antibacterial and wound healing activities.
Review in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Antibacterial potential, DNA binding and molecular docking investigations of newly green synthesized zinc oxide/chitosan/vancomycin nanocomposite using Bacillus licheniformis ATCC 4527 against some drug-resistant bacteria.Microbial cell factories · 2026Article
- Biomolecular strategy for designing antibiotic-silver nanoparticles conjugate via nitrate reductase mediated β-lactamase inhibition with molecular docking insights.Scientific reports · 2026Article
- Exploration of recent advancements of nanoparticle-based therapeutics emphasis on diabetic-related chronic wound management: a comprehensive review.Archives of pharmacal research · 2026Review
- A comparative analysis of Fagonia indica extracts and green synthesized nanoparticles for the determination of antioxidant potential.Scientific reports · 2025Article
- Removal of Zn(II) and Ag(I) byToxics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The discovery of antibiotics in the 20th century has played a crucial role in contemporary medicine for treating bacterial infections; however, the rise of antimicrobial resistance poses a significant threat to their efficacy, creating a global health crisis. On the other hand, the lack of discovery of new antibiotics for overcoming resistance has stagnated. In this context, metallic nanoparticles (MNPs) prepared with green approaches (P-MNPs) have emerged as viable options for combating multidrug-resistant bacteria and inhibiting biofilm formation. Additionally, when combined with commercial antibiotics, P-MNPs enhance drug delivery, improve circulation, and effectively target bacteria, reducing the required dosage and expanding antibacterial activity while maintaining biocompatibility. In this review, synergistic antibacterial mechanisms of P-MNPs and antibiotics (nAbts), their wound healing and cytotoxicity studies are underscored, which paves a road map for the researchers and medical practitioners to use nAbts in clinical translations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.